Tag: GILD

  • Gilead Pullback a Potential Overreaction

    Gilead Pullback a Potential Overreaction

    Gilead (GILD) fell about 10%, or $8.86 on a disappointing cancer drug study. According to NBC, “The company did not significantly extend the lives of patients with certain lung cancer in a late-stage trial. The phase-three study was part of an effort to expand the use of Trodelvy, which is already approved to treat some…

  • Gilead Just Invested Millions in These Two Biotech Stocks

    Gilead Just Invested Millions in These Two Biotech Stocks

    Gilead Sciences (GILD) just invested millions in two biotech stocks. One of those investments was in AlloVir (ALVR), which develops drugs to treat or prevent viral diseases. Gilead invested $11 million in the company on June 27 and now owns another 2.9 million shares of the stock. With ALVR, the company also just released final…